Get the latest news on Alterity Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on PRNAF performance

Latest Alterity Therapeutics Stock News | OTC:PRNAF | Benzinga

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

ALTERITY THERAPEUTICS LTD by Alterity Therapeutics Limited

Alterity Therapeutics Ltd

Alterity Therapeutics

News

Intraday Update

Markets

Movers

Trading Ideas

AAGC

AAGIY

AAWC

ABCE

ABNAF

ABVC

ACAM

ACCA

ACCR

ACMC

ACRFF

AERG

AERO

AFPW

AGFAF

AGHI

AGLDF

AHELF

AINSF

AIRT

ALAN

ALPE

ALPP

ALST

AMBS

AMHPF

AMMX

AMPG

ANTH

ANXGF

APAFF

APHD

APNHY

ARAFF

AREB

ARRRF

ARYC

ARZTY

ASNT

ATDS

ATHOF

AUOTY

AVBH

AVOI

AVVH

AXTG

BABB

BANJ

BAYK

BBAVY

BBKCF

BBRRF

BCCI

BCCLF

BDVB

BEPTF

BIOIF

BIPH

BIXT

BKIRF

BKRKF

BKRKY

BLAGF

BLIAQ

BMRK

BNCC

BOLYY

BONTQ

BOTJ

BREUF

BRGGF

BRLXF

BRPHF

BRUZF

BRYN

BRZL

BSCA

BSGC

BTTR

BXNG

BXRX

BYOC

CALB

CAWW

CBAN

CBAT

CBDL

CBMJ

CBYAA

CCCGY

CCLAF

CCOHY

CDTI

CDUAF

CELZ

CESDF

CGNH

CGOL

Stocks That Hit 52-Week Lows On Tuesday

Comments

Alterity Therapeutics Stock News

News

Latest Alterity Therapeutics Stock News | OTC:PRNAF | Benzinga

Tuesday, March 24, 2020

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga